Eric Singhi/X
Nov 9, 2024, 11:27
Eric K. Singhi: Tarlatamab-Induced Cytokine Release Syndrome in Extensive-Stage SCLC
Eric K. Singhi, Assistant Professor in the Department of General Oncology within the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, shared a post on X:
“Small Cell, Big Challenge? Managing Tarlatamab-Induced Cytokine Release Syndrome in Extensive-Stage SCLC.
Proud of my incredible team—first year fellow, Dr. Mitchell Parma, & amazing APP, Linda Soy—for presenting our work at the MD Anderson Cancer Center IOTOX Symposium!”
Eric K. Singhi is a thoracic and head and neck medical oncologist, currently serving as an Assistant Professor in the Department of General Oncology within the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, TX.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56
Nov 12, 2024, 22:50
Nov 12, 2024, 22:46
Nov 12, 2024, 22:43
Nov 12, 2024, 19:34